Nazwa produktu: Dehydronandrolone Acetate
Synonimy: Dehydronandrolone Acetate;Dehydronandrolone-6 Acetate
CAS: 2590-41-2
MF: C20H26O3
MW: 314.42
poseł: 95-98°C
Temperatura przechowywania: Controlled Substance, -20°C Zamrażarka
Wygląd: biały proszek
Dehydronandrolone acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate(CAS: 2590-41-2) is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate is an effective compound that produces quality, long-lasting muscle gains,with the biggest side effect being water retention.
| Elementy analizy |
Specyfikacja |
Wyniki |
| Opis |
Krystaliczny proszek o barwie białej do jasnożółtej |
Biały krystaliczny proszek |
| Temperatura topnienia |
≥100℃ |
107℃ |
| Specyficzna skręcalność optyczna |
-20°～-26° |
-22.5° |
| Strata przy suszeniu |
≤0,5% |
0.15% |
| Identyfikacja |
Test preparation has maximum
absorption at 282±2nm by
ultraviolet – visible spectrophotometry. |
Wykwalifikowany |
| Maximum single impurity |
≤1,0% |
0.3% |
| Totalne zanieczyszczenia |
≤5,0% |
0.8% |
| Analiza |
≥95.0% |
99.45% |
| Wniosek |
Wykwalifikowany |
